Thymic neuroendocrine tumors

Thorac Surg Clin. 2014 Aug;24(3):327-32. doi: 10.1016/j.thorsurg.2014.05.007.

Abstract

Thymic neuroendocrine tumors are rare and account for approximately 2% to 5% of all thymic tumors. Despite the suggestion of benign behavior implied by their name, thymic carcinoids have been noted to present a more aggressive biologic behavior than their counterparts in other sites. Because of the lack of data, adequate-sized prospective trials are required for validation, and the enrollment of patients with advanced disease into available clinical trials is encouraged.

Keywords: Chemotherapy; Neuroendocrine tumors; Outcome; Radiotherapy; Surgery; Thymus.

Publication types

  • Review

MeSH terms

  • Humans
  • Neuroendocrine Tumors* / diagnosis
  • Neuroendocrine Tumors* / therapy
  • Thymoma / diagnosis
  • Thymoma / therapy
  • Thymus Neoplasms* / diagnosis
  • Thymus Neoplasms* / therapy